ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2025
Elucidation of roles of serine/threonine phosphatases PP1 and PP2A in mediating CCK-stimulated growth and enzyme secretion in pancreatic acinar cells.
Article in American journal of physiology. Gastrointestinal and liver physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of serine/threonine phosphatases 1 and 2A in pancreatic acinar fluid and electrolyte secretion.American journal of physiology. Gastrointestinal and liver physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Serine/threonine phosphatases, protein phosphatases 1 and 2A (PP1 and PP2A), play important roles in mediating cellular signaling in different tissues to different stimuli, including glycogen metabolism, protein synthesis/growth, and secretion. However, the roles of PP1/PP2A in pancreatic acinar cell secretion/growth are both unclear and controversial. To address this issue, in the present study, we examined the ability of gastrointestinal hormones/growth factors (GFs) to activate PP1 and PP2A and the signaling cascades involved in rat pancreatic acini and the pancreatic acinar tumor cell line, AR42J cells. PP1 and PP2A were both detected in pancreatic acini and AR42J cells. In acini, PP1 and PP2A were activated by pancreatic secretagogues-stimulating phospholipase C (bombesin, CCK-8, and carbachol) and endothelin and by pancreatic GFs (insulin, hepatocyte growth factor, epidermal growth factor, basic fibroblast growth factor, platelet-derived growth factor, and insulin-like growth factor 1). Full CCK-8 activation of PP1/PP2A required activation of both high- and low-affinity CCK1-receptor states. Using specific PP1 and PP2 assays, in both acini and AR42J cells, experimental conditions were established, where calyculin A, a known nonselective PP1/PP2A inhibitor, inhibited activation of both, whereas okadaic acid and fostriecin inhibited only PP2A activation and tautomycetin inhibited only PP1 activation. Under these conditions, CCK-stimulated enzyme secretion and stimulation of p44/42, a key mediator of growth, required PP2A activation, without activation of PP1. Using specific siRNA for PP1/PP2A in AR42J cells, similar results were found. These results establish that only PP2A activation is essential for CCK-mediated stimulation of growth and enzyme secretion in pancreatic acinar cells and pancreatic acinar AR42J tumor cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.